Connect

Innovate

Transform

Where research meets possibility—and action begins

  • 25-26 May 2026

  • Barcelona Biomedical Research Park: PRBB

  • Flagship Event

Join the leading think-tank on SLD, where we connect healthcare professionals, patient advocates, and industry to exchange best practices in the prevention, diagnosis, treatment, and management of MASLD/MASH. Through innovative, actionable strategies, we’re driving transformative efforts to end MASLD/MASH as a public health threat by 2030.

About the Think-tank

The flagship event* of the Global Think-tank on Steatotic Liver Disease consists of three main sessions and an “open space”, with key topics focused on steatotic liver disease prevention, diagnosis, treatment, management and public health and policies.

Expert panels will present evidence-based case studies showcasing the latest advances in models of care including non-invasive tests. Leading hepatologists, endocrinologists, primary care physicians, nurses, and nutritionists will contribute to building a community of practice by exploring collaborative and integrated approaches for managing MASLD/MASH.

Discussions will also address key topics such as patient engagement, health literacy, and raising broader awareness within healthcare systems and among the public. Particular attention will be given to the inclusion of MASLD/MASH in clinical guidelines and testing policies, as well as tackling health inequities and disparities where they arise.

*Attendance is limited. All applications for registration are reviewed, and will be notified of invitation status and fee via email within one week.

prevention

Prevention

thinktank ISGlobal_flechas-14
thinktank ISGlobal_flechas-15
diagnosis

Diagnosis

Treatment

thinktank ISGlobal_flechas-14
thinktank ISGlobal_flechas-15

Management

policy

Public health
& policy

Think-tank leadership

Jeffrey V Lazarus – Director

Professor, CUNY Graduate School of Public Health and Health Policy, NY, USA. Research Professor, Barcelona Institute for Global Health (ISGlobal), Spain. Director, MASH Cities.

Jörn M Schattenberg – Co-director

Professor, Director. Department of Internal Medicine. Saarland University Medical Centre, Germany.

Naim Alkhouri – Co-director

Chief Academic Officer, Summit Clinical Research. Director of the SLD Programme, Clinical Research Institute of Ohio, USA.

Dídac Mauricio – Local Chair

Department of Endocrinology & Nutrition. CIBERDEM, Hospital de la Santa Creu i Sant Pau, Spain. Professor, University of Vic. Central University of Catalonia, Vic, Spain.

Jacqui Thornton – Event Moderator

Award-winning health journalist writing for the Lancet, BMJ, Nature and more. She is an accomplished moderator of conferences, advisory boards and webinars, and a speaker and opinion former on health and the media.

Scientific committee

  • Ajay Duseja, Professor & Head of Dep. of Hepatology, Post Grad Institute of Medical Education & Research, Chandigarh, India.
  • Amit Gupta, Secretary Global Advisory Board ADA / Chair, School of Diabetes and Education Committee, International Diabetes Federation, India.
  • Carolina Lapena Estella, Primary Care Nurse, Primary Heathcare Center Sanllehy, Barcelona Institut Català de la Salut (ICS), Spain.
  • Cyrielle Caussy, Lyon University, Lyon South Hospital, France.
  • Emmanuel Tsochatzis, Hepatologist, Royal Free Hospital, UK.
  • Fasiha Kanwal, Professor of Medicine; Director, Baylor College of Medicine; Institute for Clinical and Translational Research, USA.
  • Ferdinant M. Sonyuy, Health Economist Executive Director, Africa NCDS Network (ANN), Cameroon.
  • Gema Frühbeck, Obesity Area, Dept. of Endocrinology & Nutrition, CIBEROBN, University of Navarra Clinic, IdiSNA, Spain.
  • Giada Sebastiani, Hepatologist, McGill University Health Centre / President, Canadian Association for the Study of the Liver, Canada.
  • Graciela Castro-Narro, Hepatologist, Medica Sur Hospital / National Institute of Sciences and Nutrition “Salvador Zubirán” / Past President of the Latin American Association for the Study of the Liver, Mexico.
  • Hannes Hagström, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Helen Jarvis, Primary Care – General Practitioner / Clinical Lecturer, Newcastle University, UK.
  • Jérôme Boursier, Hepatologist / Head of the HIFIH Laboratory, Angers University / Head of the Hepato-Gastroenterology and Digestive Oncology Department, Angers University Hospital, France.
  • Jordi Serrano Pons, Medical Doctor, Digital and Global Health Expert, Spain.
  • Kenneth Cusi, Professor of Medicine at the Division of Endocrinology, Diabetes & Metabolism, University of Florida, USA.
  • Kristina Curtis, CEO, Applied Behaviour Change. Honorary Lecturer, University College London, UK.
  • Kushala Abeysekera, Hepatologist, Bristol Royal Infirmary / Consultant Senior Lecturer in Liver Disease Epidemiology, Uni of Bristol, UK.
  • Luis Antonio Diaz, Assistant Professor, University of California San Diego, USA.
  • Michael Ninburg, Executive Director Emeritus, HEP, USA.
  • Meena Bansal, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, USA.
  • Manuel Romero-Gómez, Virgen del Rocío University Hospital, University of Seville, Spain.
  • Marco Arrese, Hepatologist, Pontificia Universidad Católica de Chile / Vice President, ALEH, Chile.
  • Mark Swain, Hepatologist, Professor of Medicine, University of Calgary, Canada.
  • Maru Rinella, Gastroenterologist, Director, Metabolic and Fatty Liver Disease Dept, University of Chicago, USA.
  • Meena Bansal, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, USA.
  • Michael Betel, President, Fatty Liver Alliance, Canada.
  • Michael Roden, Scientific Exec. Officer, German Diabetes Center (DDZ) Prof/Director, Dept. of Endocrinology & Diabetology, Heinrich Heine Univ. & Univ. Hospital Düsseldorf, Germany.
  • Nikos Dedes, Patient advocate, Greece.
  • Paul Brennan, University of Dundee, Scotland, UK.
  • Rogério Ribeiro, Research Lead, APDP, Diabetes Portugal / Assistant Professor, ECTS – School of Health Sciences and Technologies, Lusófona University, Portugal.
  • Scott Isaacs, Endocrinologist, Emory University School of Medicine, USA.
  • Shira Zelber-Sagi, University of Haifa, The Tel-Aviv Medical Center, Israel.
  • Silvana Pannain, Associate Professor of Endocrinology Diabetes and Metabolism, University of Chicago / Obesity Medicine Director, Center for Weight and Metabolic Health, USA.
  • Sonal Kumar, Hepatologist, Weill Cornell Medicine, USA.
  • Stefan Buttigieg, Resident Specialist, Public Health Medicine, Ministry for Health and Active Ageing, Malta.
  • Vincent Wong, The Chinese University of Hong Kong.
  • Volkan Demirhan Yumuk, Professor of Medicine- Istanbul University, Cerrahpaşa Faculty of Medicine / President – European Association for the Study of Obesity, Turkey.
  • Wendy Spearman, University of Cape Town, South Africa.
  • Yusuf Yilmaz, Marmara University, Turkey.

The Venue

Situated in one of Barcelona’s most dynamic innovation hubs, the Barcelona Biomedical Research Park (PRBB) provides an inspiring environment for hosting events. The building brings together leading research institutions and professionals from around the world, fostering collaboration and knowledge exchange.

Its modern architecture and open design reflect the spirit of scientific discovery that defines the venue. Each year, around 300 scientific sessions and conferences are held within the research park.

Become a sponsor

Interested in becoming a sponsor of the event?

Showcase your business to a diverse audience, including hepatologists, endocrinologists, primary care physicians, researchers, the patient community, and representatives from the private sector.

As a sponsor, you’ll get unique visibility through strategic logo placements, exhibition space, social media exposure, networking opportunities, and more. Contact our sponsorship team to find out more about the various sponsorship packages available.

Contact sponsorship team

Additional inquiries

Would you like to collaborate or partner with us? Do you have any questions?

Feel free to reach out!

Terms and conditions*